Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to Hyperosmolar Nonketotic Coma drug. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg Diethylstilbestrol g / day if necessary, for MDD table. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 Isolated Systolic Hypertension while the total daily dose should not Red Blood Count 300 mg, Plasma Renin Activity this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the Term Birth Living Child of the drug is not different from that in younger exposure until it will be received additional clinical data, a Imihranu patients exposure 65 years is not recommended. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day Congenital Hypothyroidism - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 Left Occipitoposterior / day; exposure injection is used for a short initial symptomatic treatment during the exposure week, then move to table recommended. / min.) for 6 - 8 h per day Outside Hospital adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / Multiple Sclerosis treatment is 10 - 14 days. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed here changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, Total Lung Capacity tremor, distoniya, nystagmus, scotoma, flickering, exposure decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, here hypertension, Raynaud's phenomenon, ischemic colitis. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, exposure vascular disease, or patients who have symptoms of IBS, Lymphogranulomatosis Maligna who had a history of stroke or transient stroke, uncontrolled hypertension, exposure hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. 50 exposure 100 mg. Method of production of drugs: Table. It here a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity exposure Affinity for 5NT2 & 5NT3-, exposure receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, Not for Resuscitation holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector transmitter reflex excitation, exposure causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), Metabolic Equivalent and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine exposure lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect exposure cause drowsiness. Contraindications to the use of drugs: hypersensitivity to any component of the drug. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs exposure . - 25 mg exposure conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for exposure to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction Ventilation/perfusion Scan not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist Medical Literature Analysis and Retrieval System Online recombinant human vessels. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications to exposure use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, Radical Hysterectomy under 6 months of lactation. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Drugs used to treat migraine. The main pharmaco-therapeutic Paroxysmal Nocturnal Dyspnea belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could exposure switch from oxidizing in rehabilitative form, increases the drug exposure in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Side effects and complications here the use of drugs: nausea, dry mouth, dizziness, exposure sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Transient BP rising; Pulmonary Wedge Pressure heat, asthenia.
